Delivery Order SPE2DB22D2206-SPE2DB25FFS13
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,354.76, is for the provision of Pulmozyme 1 mg/ml ampul 2.5 ml, a medication used to treat cystic fibrosis. The contract has an ultimate completion date of November 19, 2024 and is a Firm Fixed Price (FFP) contract type. This DO is associated with AmerisourceBergen's larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a ceiling value of $5,444.32 and an ultimate completion date of January 14, 2025. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $30,034.27 and is for the delivery of the drug Pulmozyme, a 1 mg/ml ampul with a 2.5 ml volume. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through September 26, 2023. This IDC, valued at $999,999,999, serves as a primary vehicle for...
This is a $27,880.43 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has an ultimate completion date of September 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL. The $2,410.99 firm fixed-price contract has a completion date of March 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA for a wide range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This...
This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) for the supply of Pulmozyme 1 mg/mL ampules. The contract is valued at $10,129.21 and has a firm fixed price pricing type. The place of performance is Conshohocken, Pennsylvania, and the ultimate completion date is September 25, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $12,909.47, is for the supply of the pharmaceutical product Pulmozyme in 1 mg/mL ampules with a 2.5 mL volume. The delivery order has a firm-fixed price and is set to be completed by September 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $15,236.33, has a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,001.35, is for the delivery of Pulmozyme 1 mg/ml ampuls with a 2.5 ml dosage. The contract has a completion date of February 16, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a ceiling value of $15,622.39 and a completion date of March 5, 2024. The contract is a firm fixed-price, open competition award with no set-aside designation. Amerisourcebergen holds a...